Reta 5mg (GLP-3)

Buy Reta 5mg: Research Compound for Advanced Studies

Advanced peptide research requires compounds of the highest purity and reliability. Reta, a triple receptor agonist, is the next generation of metabolic pathway research compounds. This sophisticated peptide targets three receptors at once, giving researchers the ability to investigate complex metabolic mechanisms through controlled isolation process methods.

Research shows that Reta’s tri-receptor approach gives valuable insights into the body’s natural pathways of metabolic regulation. For scientists studying incretin biology, glucagon signaling and integrated metabolic responses, this compound is a powerful tool for experimental design.

Molecular Structure of Reta

Reta’s molecular structure demonstrates advanced peptide engineering. The compound has:

Amino Sequence: Triple receptor agonist peptide targeting GLP-1, GIP and glucagon receptors

Molecular Formula: Advanced version of tirzepatide with enhanced metabolic effects through systematic expansion of binding capabilities

Molecular Weight: 4.5 kDa, optimized for receptor specificity and stability

PubChem CID: Available upon request for research documentation

CAS Number: 2381089-83-2

The peptide structure has short chain amino acids configured to achieve predefined physicochemical properties for multi-receptor binding. This molecular design is years of peptide synthesis techniques, using continuous manufacturing principles to ensure consistent structure across batch and continuous mode production cycles.

Physical Form and Specifications

Loti Labs supplies Reta as a white powder in lyophilized powder form, maintaining stability through controlled dehydration processes. This physical form ensures long shelf life while preserving the compound’s binding affinity to all three receptors. The lyophilization process removes moisture content to minimize microbial contamination risk during storage and handling.

Each vial contains precisely measured amounts produced through equipment trains to ensure optimal yield and purity. The manufacturing process uses different equipment trains for different production stages to prevent cross-contamination between batches while maintaining the highest good manufacturing practice standards.

Mechanism of Action

Reta is a novel triple receptor agonist with precisely characterized binding affinities. Research shows specific EC50 values that mimic natural hormone interactions:

• Glucagon Receptor: 5.79 nM binding affinity
• GLP-1 Receptor: 0.0643 nM binding affinity
• GIP Receptors: 0.775 nM binding affinityThese binding properties allow researchers to study how multiple metabolic pathways interact. The compound design enables investigation of receptor crosstalk and downstream signaling cascades when these pathways are working together.

Receptor Interaction Pathways

Glucagon receptor activation allows research into energy expenditure and metabolic rate regulation. GLP-1 receptor engagement enables studies of insulin sensitivity and glucose homeostasis. GIP receptor interaction gives insights into nutrient-stimulated hormone release and metabolic coordination.

Research shows this tri-receptor approach has advantages over single-target compounds by allowing full metabolic pathway analysis. Scientists can study how these receptors work together, giving data not available through individual receptor studies.

Research Studies and Applications

Current research with Reta is focused on metabolic pathway interactions and receptor biology. Studies are looking into how simultaneous receptor activation affects signaling cascades, gene expression patterns and metabolic flux measurements.

Experimental Design Considerations

Researchers using Reta typically do dose-response studies with concentrations from 0.5mg to 12mg equivalent ranges in their models. The compound is stable across different experimental conditions so it’s suitable for long study protocols that require consistent compound activity over time.

Weight loss research applications investigate how tri-receptor activation affects metabolic rate, energy expenditure and appetite regulation mechanisms. These studies give valuable data about integrated metabolic responses that single-receptor agonists can’t reveal.

Research Parameters

Lab studies benefit from Reta’s consistent activity profile across different experimental conditions. The compound is stable across physiological pH ranges and temperature variations found in research settings. This reliability allows researchers to focus on experimental variables rather than compound stability issues.

Multi kg quantities production capabilities ensure research continuity for large scale purification campaigns and long study protocols. The manufacturing process uses continuous mode production methods to maintain quality across different batch sizes.

Storage and Safety Guidelines

Proper storage maintains Reta’s stability and research effectiveness. Store compounds at -20°C to -15°C in original sealed vials to preserve molecular integrity. The controlled temperature range prevents degradation while maintaining binding affinity characteristics for consistent research results.

Environmental Controls

Keep vials away from light using appropriate packaging materials for peptide preservation. Humidity controlled air systems in storage areas prevent moisture infiltration that can compromise compound stability. These environmental controls extend shelf life to 24-36 months when maintained consistently.For reconstitution, use sterile techniques with bacteriostatic water or suitable solvent supply materials. Standard operating procedures ensure consistent preparation while minimizing microbiological contamination risk. Use integrated safety workbenches to protect operators during compound handling.

Handling Protocols

Research facilities should have protocols for compound handling that address stability preservation and contamination prevention. The compound is sensitive to environmental factors so storage conditions should be controlled throughout the product life cycle.

Temperature monitoring systems ensure storage parameters are within specified ranges. Any deviation from recommended storage conditions may affect compound integrity and experimental reproducibility.

Why Buy from Loti Labs

Loti Labs uses advanced methods for Reta production to deliver extremely pure products for demanding research applications. Our manufacturing process integrates first class capabilities across all production stages, from peptide synthesis to final purification.

Quality Control

Each batch is tested using hplc to verify minimum 99% purity. Mass spectrometry analysis confirms molecular structure and active ingredients meet specification. This comprehensive testing ensures researchers receive highly active pharmaceutical ingredients for their research needs.

Stainless steel columns and solvent delivery systems are cleaning validated between production runs. This ensures equipment cleanliness prevents cross contamination and compliance with quality standards. The process has early control of contamination principles for consistent product quality.

Loti Labs products are for Research Use Only

All Reta products from Loti Labs are research only and cannot be used for human consumption. This research use only designation ensures compliance with regulations and supports scientific investigation of metabolic pathways.

Regulation

Research use only means in-vitro laboratory testing and controlled experimental protocols only. Human use is prohibited under this designation. This ensures researchers stay within boundaries while conducting scientific research.

Products are manufactured under api standards for research use. However, research use only means these compounds cannot be used as drugs, food or cosmetics. This clear definition protects both researchers and suppliers from regulatory issues.

Suitable Applications

Legitimate research applications include receptor binding studies, pathway analysis, molecular mechanism investigation, metabolic flux measurements. These applications align with the research designation and support scientific knowledge in metabolic biology.

Research institutions using these compounds must have protocols in place to comply with research use only. Documentation of intended research applications helps with regulatory compliance and scientific inquiry.

Loti Labs Shipping

Loti Labs offers fast and reliable shipping to maintain compound integrity during transport. Orders placed before 1pm EST Monday to Friday are processed same day, so minimal delay between order and shipment.

Shipping Schedule

Weekend and after hours orders are processed next business day, so consistent service regardless of order time. This ensures researchers can plan their experiments and have compounds when needed.

Specialized packaging protects compounds during transport, maintaining required temperature ranges and preventing environmental damage. This shipping protocol ensures compounds arrive ready for use.

30 Day Satisfaction Guarantee

Loti Labs stands behind product quality with a 30 day money back guarantee on all purchases. This reflects our confidence in our manufacturing standards and gives researchers peace of mind with their compound investment.

Return Policy

Unopened products can be returned within 30 days for full refund. This generous return policy recognizes that research requirements can change during project development.

The guarantee covers product quality and shipping integrity, so researchers receive compounds that meet their experimental needs. This additional security for research investment.

Third Party Testing of Every Batch

Quality assurance goes beyond internal testing with third party verification protocols. Every batch is tested using state of the art HPLC systems to confirm purity and molecular structure.

Independent Verification

Third party testing provides objective quality verification and compliance to industry standards. These independent tests verify products meet published specs and batch to batch consistency.

Testing protocols check purity levels and molecular structure integrity so researchers get compounds suitable for demanding research applications. This dual verification gives extra confidence in product quality and experimental reproducibility.

Documentation

Full testing documentation is included on every product, so researchers have the analytical data to support their experimental protocols. This includes purity analysis, molecular weight confirmation and structural verification data for research planning.

The comprehensive testing ensures when researchers buy Reta 5mg from Loti Labs they get not only a high quality compound but also the documentation to support their research. This combination of product and documentation makes Loti Labs the go to supplier for researchers who need reliable, well characterized compounds for their metabolic pathway research.

Through continuous improvement of manufacturing process and quality control, Loti Labs remains a leading supplier of research compounds. The combination of advanced manufacturing, rigorous quality control and customer service means researchers can focus on their science not compound quality.

For researchers looking for high purity Reta compounds with comprehensive quality assurance and customer service, Loti Labs is the perfect combination of product and support for research success.

Triple Agonist Mechanism: Research Context

Retatrutide is classified as a triple receptor agonist, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously. This mechanism distinguishes retatrutide from dual agonists such as tirzepatide (GLP-1/GIP) and single agonists such as semaglutide (GLP-1).

GLP-1 Receptor Activity

GLP-1 receptor agonism promotes insulin secretion, suppresses glucagon release, and slows gastric emptying. These combined effects support glucose regulation and appetite modulation in preclinical research models.

GIP Receptor Activity

GIP receptor co-agonism enhances insulin secretion in a glucose-dependent manner and may reduce gastrointestinal effects associated with standalone GLP-1 agonists. Research models also implicate GIP activity in adipose tissue regulation.

Glucagon Receptor Activity

Glucagon receptor agonism increases energy expenditure and hepatic glucose output. Research suggests glucagon activity may amplify metabolic effects observed with GLP-1/GIP co-agonism, particularly in lipid metabolism and hepatic steatosis models.

GLP Receptor Agonist Mechanism Comparison

The table below compares key mechanism characteristics across the major GLP receptor agonist classes currently under investigation or approved for clinical use.

Compound	Receptor Targets	Agonist Class	Primary Research Application
Retatrutide	GLP-1 / GIP / Glucagon	Triple agonist	Metabolic research, energy expenditure models
Tirzepatide	GLP-1 / GIP	Dual agonist	Glucose regulation, adiposity research
Semaglutide	GLP-1	Single agonist	Glucose regulation, appetite suppression research

Regulatory and Research Status: 2026

As of 2026, retatrutide holds Investigational New Drug (IND) status and has not received FDA approval for any indication. It is available exclusively for preclinical and laboratory research purposes.

• Retatrutide: IND stage — not FDA approved. Research use only.
• Tirzepatide: FDA approved (Mounjaro® for type 2 diabetes; Zepbound® for chronic weight management).
• Semaglutide: FDA approved (Ozempic® for type 2 diabetes; Wegovy® for chronic weight management).

This compound is supplied for research purposes only. Not for human use. No claims are made regarding safety or efficacy in humans.

Conclusion

Reta is a game changer in peptide research, a powerful tool to investigate complex metabolic pathways with its unique triple receptor agonist mechanism. Manufactured under the strictest good manufacturing practice and using advanced purification equipment, Reta ensures high purity and consistency for scientific research. Researchers can rely on Loti Labs for high quality Reta 5mg products for research applications from metabolic regulation to weight loss mechanisms. With quality assurance, fast production and dedicated customer service, Loti Labs is a trusted partner in peptide research.

Structural Architecture and Protease Stability of Retatrutide 5mg

Retatrutide 5mg is categorized as a unimolecular chimeric peptide, a sophisticated class of “intentional polypharmacology” where three distinct hormonal actions are integrated into a single 39-amino acid sequence. Unlike compound mixtures, this single-chain peptide is engineered on a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist scaffold. Researchers utilize this backbone because it provides a stable template that has been rationally modified at specific positions—notably 2, 13, and 27—to facilitate cross-reactivity with the GLP-1 and glucagon receptors. This structural integration allows for a synchronized activation of G-protein coupled receptors involved in metabolic homeostasis.

A critical feature for laboratory stability and pharmacokinetic research is the inclusion of α-aminoisobutyric acid (Aib) at the second position of the N-terminus. This specific modification grants the peptide significant resistance against Dipeptidyl Peptidase-4 (DPP-4), the primary enzyme responsible for the rapid degradation of endogenous incretins. Furthermore, the molecule is conjugated with a C20 fatty diacid moiety (eicosanedioic acid). This acylation allows the compound to bind reversibly to serum albumin, creating a depot effect that extends the terminal half-life to approximately six days. For researchers, this long-acting profile is essential for investigating steady-state pharmacological effects through once-weekly administration protocols, ensuring consistent receptor occupancy throughout the study duration.

Triple Agonist Mechanism and Thermogenesis Research for Retatrutide 5mg

The pharmacological profile of retatrutide 5mg is defined by its “triple agonist” activity, targeting the GIP, GLP-1, and glucagon (GCGR) receptors with a specific potency bias. In research settings, the molecule exhibits its highest affinity for the GIP receptor, while providing relatively attenuated but significant activation of the GLP-1 and glucagon receptors. This balanced activation pattern is designed to explore how overlapping signaling pathways influence energy balance. While GLP-1 and GIP signaling are traditionally associated with nutrient-stimulated insulin secretion and appetite regulation, the inclusion of glucagon receptor agonism introduces a novel research vector: the stimulation of thermogenesis and the upregulation of energy expenditure.

• Energy Expenditure: GCGR activation signals the body to increase heat production, potentially balancing caloric intake with a heightened metabolic rate in experimental models.
• Hepatic Lipid Oxidation: Research indicates that the glucagon component targets the liver specifically, promoting the mobilization of stored triglycerides and enhancing fatty acid oxidation processes.
• Regulatory Classification: As of early 2026, this compound is classified as an Investational New Drug (IND) under regulatory oversight. It remains a first-in-class investigational peptide and is strictly intended for laboratory research use. It is not FDA-approved for clinical, therapeutic, or diagnostic use in humans.

References

1. NovoPro Labs. Reta (LY3437943) Peptide Information.
2. Manufactry. Peptide Reta Supplier – High Purity 99% GMP Certified for Research.
3. Wuhan Newtop Biotech Co., Ltd. Reta Peptide Production and Purification.
4. Zhaobo Bio. Customized Research Peptide Reta 5mg 10mg 30mg 60mg – 99% Purity.
5. Handom Chemical. Reta 5mg/10mg/15mg/20mg/30mg Latest Price and Specifications.

{
“@context”: “https://schema.org”,
“@type”: “FAQPage”,
“mainEntity”: [
{
“@type”: “Question”,
“name”: “What is Retatrutide 5mg used for in research?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “Retatrutide 5mg is a low-dose research compound used in laboratory studies investigating tri-receptor agonism of GIP, GLP-1, and glucagon pathways. It is not approved for human use and is sold exclusively for in vitro and preclinical research applications.”
}
},
{
“@type”: “Question”,
“name”: “What receptors does Retatrutide 5mg target?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “Retatrutide is a triple-receptor agonist that targets GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors simultaneously. This multi-receptor activity makes it a valuable tool for metabolic pathway research.”
}
},
{
“@type”: “Question”,
“name”: “Is Retatrutide 5mg FDA-approved?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “No. Retatrutide 5mg sold by Loti Labs is strictly a research-grade compound for laboratory use. It is not FDA-approved for clinical, therapeutic, diagnostic, or human consumption purposes.”
}
},
{
“@type”: “Question”,
“name”: “What studies have been published on Retatrutide?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “Clinical research on retatrutide has been published in peer-reviewed journals including the New England Journal of Medicine (Jastreboff et al., 2023) and The Lancet. Phase 3 TRIUMPH trials (NCT05579782 and related) are ongoing as of 2026.”
}
},
{
“@type”: “Question”,
“name”: “How should Retatrutide 5mg be stored for research?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “For optimal stability, store lyophilized Retatrutide 5mg at -20u00b0C. After reconstitution, keep at 2u20138u00b0C and use within 14 days. Avoid repeated freeze-thaw cycles. All handling should follow standard laboratory safety protocols.”
}
}
]
}